What does Conveyxo do?
Paracrine Biologicals specializes in the development of innovative therapeutic solutions based on cell and gene therapies. The company focuses on harnessing the power of paracrine signaling to enhance tissue regeneration and repair. Their research aims to address unmet medical needs in various fields, including orthopedics and cardiovascular health.
- Signals
-
Reporting lossesReporting losses € -1.61M
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.57The current ratio is below 1: may be insufficient to cover short-term debt.
Negative EBITDANegative EBITDA € -442KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.39MStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 91KPositive operating cash flow in the latest financial year.
Healthy social debtHealthy social debt 7.8%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-45K
|
€
-76K
|
€
-440K
|
€
-439K
|
|
|
€
-442K
|
€
-295K
|
€
-568K
|
€
-478K
|
|
|
€
-1.61M
|
€
-947K
|
€
-1.09M
|
€
-1.41M
|
|
|
€
1.39M
|
€
2.96M
|
€
2.99M
|
€
1.81M
|
|
|
13.52%
|
37.32%
|
56.98%
|
54.82%
|
|
|
€
8.88M
|
€
4.97M
|
€
2.26M
|
€
1.49M
|
|
|
€
1.61M
|
€
1.54M
|
€
85K
|
€
2.10M
|
|
|
3.80
|
4
|
2
|
1
|
Publications 13
All publications- Siege Social 16/04/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 30/11/2023
- Capital, Actions 01/08/2023
- Demissions, Nominations 14/07/2023
- Demissions, Nominations 08/11/2022
Frequently asked questions
Answers to the most common questions about Conveyxo, based on official government data and the filed annual accounts.
What is the VAT number of Conveyxo?
The VAT number of Conveyxo is BE0725.874.259.
How many employees work at Conveyxo?
In 2025, Conveyxo employed 3.80 full-time equivalents (FTE).
When was Conveyxo established?
Conveyxo was founded in 30-04-2019.
What is the official address of Conveyxo?
The official address of Conveyxo is Avenue Jean Mermoz 32 Charleroi 6041.
What is the legal form of Conveyxo?
The juridical form of Conveyxo is Public limited company (NV/SA).
What is the annual revenue of Conveyxo?
The 2025 accounts of Conveyxo do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Conveyxo do?
Paracrine Biologicals specializes in the development of innovative therapeutic solutions based on cell and gene therapies. The company focuses on harnessing the power of paracrine signaling to enhance tissue regeneration and repair. Their research aims to address unmet medical needs in various fields, including orthopedics and cardiovascular health.
Is Conveyxo a reliable company?
Conveyxo is a registered Rechtspersoon with company number 0725.874.259 and can be verified through the official CBE database.
What is the credit limit of Conveyxo?
The estimated credit limit of Conveyxo is €48,957.
Is Conveyxo still active?
Conveyxo currently has the status "Normal situation" and is active.